Linical is a global Contract Research Organization which provides the full spectrum of drug development services from early stage to large-scale, multinational studies.

Established in 2005 by a group of entrepreneurs at a major Japanese pharmaceutical company, Linical has actively expanded around the world to become the first Japanese Headquartered Global CRO capable of delivering a one-stop service for large-scale projects, covering all key markets in Asia-Pacific, Europe, and North America.

We are focused on addressing unmet medical needs in Oncology, Immunology and CNS, also having a strong record of successfully delivered services in other areas, with strengths in infectious disease, endocrinology, and cystic fibrosis.